Psychedelic Therapies for Psychiatric Disorders: Introduction and Early Results_Online

Basic neuroscientific research on the mechanisms underlying cognitive, affective, and social processes have been slow in penetrating real-world psychology/psychiatry clinics. This is a missed opportunity for maximizing and advancing our understanding of core patterns of psychopathology and treatment response in neuropsychiatric disorders. This series will bring together members from the neuroscience, medical, and psychiatry/psychology communities to translate basic science findings into real-world clinical practice. 

Topic for this Session: “Psychedelic Therapies for Psychiatric Disorders: Introduction and Early Results” 

Presented by: Josh Woolley, MD, PhD

Target Audience

This program was designed for physicians, nurses, nurse practitioners, and psychologists.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Summarize some of the recent clinical trials and other research done on Psilocybin.
  • Evaluate the available safety and efficacy of Psilocybin therapy for the treatment of depression associated with bipolar disorder
  • Review the active/lethal dose ratio and dependence potential of psychoactive drugs.

Suggested Additional Reading:

  • Psilocybin-Assisted Group Therapy and Attachment: Observed Reduction in Attachment Anxiety and Influences of Attachment Insecurity on the Psilocybin Experience. ACS Pharmacol Transl Sci. 2021 Apr 09; 4(2):526-532. Stauffer CS, Anderson BT, Ortigo KM, Woolley J. PMID: 33860182; PMCID: PMC8033604.
  • Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study. EClinicalMedicine. 2020 Oct; 27:100538. Anderson BT, Danforth A, Daroff PR, Stauffer C, Ekman E, Agin-Liebes G, Trope A, Boden MT, Dilley PJ, Mitchell J, Woolley J. PMID: 33150319; PMCID: PMC7599297.
  • Psychedelic-Assisted Group Therapy: A Systematic Review. J Psychoactive Drugs. 2019 Apr-Jun; 51(2):174-188. Trope A, Anderson BT, Hooker AR, Glick G, Stauffer C, Woolley JD. PMID: 30950777; PMCID: PMC6650145.
    Course summary
    Available credit: 
    • 1.00 AMA PRA Category 1 Credit™
      The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
    • 1.00 ANCC
      UPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
    • 1.00 APA
    • 1.00 Attendance
    Course opens: 
    04/15/2022
    Course expires: 
    04/15/2025
    Part of: 
    Neurocognitive Therapies and Translational Research Webinar Series

    Speaker:  Josh Woolley, MD, PhD.

    Planning Committee: 

    Angela Fang, PhD
    Judy Callan, PhD RN
    Maria Kryza-Lacombe, PhD
    Greg Siegle, PhD
    Andrew Peckham, PhD
    Rudi De Raedt, PhD
    Michael Thase, MD

    Conflict of Interest Disclosure

    Dr. Woolley discloses that he receives grant/research support from Usona Institute, and an MDMA Phase three Trial sponsored by MAPS.  He is a consultant for Silo Pharmaceutical, Filament Health and Alvarius Pharmaceutical.

    No planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.

    Disclaimer Statement

    The information presented at this CME program represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by, the UPMC Center for Continuing Education in the Health Sciences, UPMC / University of Pittsburgh Medical Center or Affiliates and University of Pittsburgh School of Medicine.  Reasonable efforts have been taken intending for educational subject matter to be presented in a balanced, unbiased fashion and in compliance with regulatory requirements. However, each program attendee must always use his/her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.

     

    In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    Physician (CME)

    The University of Pittsburgh designates this [replace with applicable format: live webinar activity for a maximum of 1 AMA PRA Category 1 Credit[s]™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Nursing (CNE)

    The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hours.

    Psychology (APA)

    Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP office maintains responsibility for the content of the programs. 

    Available Credit

    • 1.00 AMA PRA Category 1 Credit™
      The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
    • 1.00 ANCC
      UPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
    • 1.00 APA
    • 1.00 Attendance
    Please login or register to take this course.

    Choose Register/Complete Course to complete the module.

    First time Users: If you have never completed training on this website, please select register in the upper right hand corner of the webpage.

    Returning Users: If you have completed training on this website, please log in in the upper right hand corner of the webpage.